 |
市場調查報告書
商品編碼
2051343
心臟人工器官市場：依產品類型分類Cardiac Prosthetic Devices Market, By Product Type |
||||||
預計到2026年，心臟假體市場規模將達到98.1億美元，2033年將達到185.2億美元。預計從2026年到2033年，該市場將以9.5%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 98.1億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 9.50% | 2033年市場規模預測： | 185.2億美元 |
心臟假體醫療設備包括機械式和組織來源的人工心臟瓣膜、環狀成形術環、心律調節器和去心房顫動導線、組織補片、人工心臟和心室輔助裝置。這些裝置用於替換受損或病變的心臟原有瓣膜。在預測期內，高血壓發生率的上升預計將推動全球心臟假體醫療設備市場的成長。此外，研究的進步和新產品的推出預計也將進一步擴大市場規模。
市場動態
主要市場參與者正致力於採取各種成長策略，包括產品發布和合作，以加強產品系列和市場地域覆蓋，預計這將推動全球心臟醫療設備市場在預測期內的成長。例如，2023年6月8日，醫療設備製造商雅培公佈了其經導管瓣膜修復（TEER）裝置「MitraClip」和全球首款微創三尖瓣修復裝置「TriClip」的臨床結果數據。這些數據證實了該公司針對二尖瓣逆流（MR）和三尖瓣逆流（TR）的結構性心臟解決方案在廣泛的心臟瓣膜逆流患者群體中的有效性。
同樣，2022 年 10 月，醫療設備製造商 Celix Medical 宣布與另一家醫療設備製造商 Osipka Medical 合作，為患有心臟衰竭和其他心臟疾病的患者開發心臟心律調節器。
此外，2022年2月，醫療設備製造商雅培宣布，作為AVEIR DR i2i主要臨床試驗的一部分，已開始將雙腔無導線心律調節器系統植入患者體內。雅培在臨床臨床實驗中植入Aveir雙腔無導線心律調節器，體現了最先進的無導線心律調節器技術。
本次調查的主要特點
- 本研究揭示了各個細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數創建了全球心臟假體設備市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
- 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
- 《全球心臟人工器官設備市場》報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 透過對全球心臟假體器官裝置市場進行分析時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因子
- 市場機遇
- 影響分析
- 近期產品發布
- 流行病學
- 併購和合作
- 監管趨勢
- 主要進展
- PEST分析
- 夥伴關係方案
- 品牌和定價分析
- 銷售代理情況
- 心臟瓣膜和心律調節器概述
- 波特的分析
- 技術進步
- 主要進展
- 市場趨勢
- 心臟人工器官成長與需求的未來展望
- 按銷售收入排名的主要公司
第4章 全球心臟人工器官市場：依產品類型分類，2021-2033年
- 心臟瓣膜
- 心律調節器
第5章 全球心臟人工器官市場：依最終用戶分類，2021-2033年
- 醫院
- 專科診所
- 門診手術中心
- 其他（學術和研究機構及其他）
第6章 全球心臟假體市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 北非
- 中非
- 南非
第7章 競爭情勢
- Abbott
- Artivion, Inc.
- Medtronic
- Boston Scientific Corporation
- Edwards Lifesciences Corporation.
- Siemens Healthcare Private Limited
- LivaNova PLC（Sorin Group）
- Asahi Kasei Corporation.
- OSYPKA MEDICAL
- Lepu Medical
- MicroPort Scientific Corporation.
- Vitatron
- Koninklijke Philips NV,
- Progetti srl
- Shree Pacetronix Ltd.
第8章
- 調查方法
- 關於本公司
Cardiac Prosthetic Devices Market is estimated to be valued at USD 9.81 Bn in 2026 and is expected to reach USD 18.52 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 9.81 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.50% | 2033 Value Projection: | USD 18.52 Bn |
Cardiac prosthetic devices include mechanical and tissue prosthetic heart valves, annuloplasty rings, pacemaker and defibrillator leads, tissue patches, artificial hearts, and ventricular assist devices. These are used to replace the heart's native valves that have been harmed or become ill. Over the forecast period, rising levels of hypertension are anticipated to fuel market expansion for cardiac prosthetic devices worldwide. The market is also expected to rise as a result of increased research and product introductions.
Market Dynamics
The key market players are focused on adopting various growth strategies such as product launches, partnerships, and others to strengthen their product portfolio and geographical presence in the market, which in turn is expected to drive the growth of the global cardiac prosthetics devices market over the forecast period. For instance, on June 8, 2023, Abbott, a medical device company, announced result data for MitraClip, which is a transcatheter edge-to-edge repair (TEER) device, and TriClip, a first-of-its-kind minimally invasive tricuspid heart valve repair device. The data reinforce the capabilities of the company's structural heart solutions for both mitral and tricuspid regurgitation (MR and TR) across a broad range of patient groups battling leaky heart valves.
Similarly, in October 2022, Ceryx Medical, a medical device company, in partnership with Osypka Medical, a medical device company, announced the development of a heart-pacing device for patients with heart failure and other cardiac conditions
Furthermore, in February 2022, Abbott, a medical device company, announced the launch of patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i pivotal clinical study. The implant of Abbott's investigational Aveir dual-chamber leadless pacemaker represents technological leadless pacing technology.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cardiac prosthetics devices market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott, Artivion, Inc., Medtronic, Boston Scientific Corporation, Edwards Lifesciences Corporation., Siemens Healthcare Private Limited, LivaNova PLC (sorin group), Asahi Kasei Corporation., OSYPKA MEDICAL, Lepu Medical, MicroPort Scientific Corporation., Vitatron, Koninklijke Philips N.V., Progetti srl and Shree Pacetronix Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global Cardiac Prosthetics Devices Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac prosthetics devices market.
Market Segmentation
- Global Cardiac Prosthetic Devices Market, By Product Type (Revenue, USD Bn, 2021 - 2033):
- Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Stented tissue valve
- Stentless tissue valve
- Transcatheter Heart Valves
- Pacemaker
- Implantable pacemakers
- Single-Chamber Battery Pacemaker
- Dual-Chamber Battery Pacemaker
- Triple-Chamber Battery Pacemaker
- External Pacemaker
- Implantable pacemakers
- Global Cardiac Prosthetic Devices Market, By End user (Revenue, USD Bn, 2021 - 2033):
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others (Academic & Research Institutes and Others)
- Global Cardiac Prosthetic Devices Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Abbott.
- Artivion, Inc.
- Medtronic
- Boston Scientific Corporation
- Edwards Lifesciences Corporation.
- Siemens Healthcare Private Limited
- LivaNova PLC (Sorin Group)
- Asahi Kasei Corporation.
- OSYPKA MEDICAL
- Lepu Medical
- MicroPort Scientific Corporation.
- Vitatron
- Koninklijke Philips N.V.,
- Progetti srl
- Shree Pacetronix Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By End user
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Partnership Scenario
- Brand and Pricing Analysis
- Distributors Landscape
- Overview on all types of heart valve and pacemakers
- Porters Analysis
- Technological Advancements
- Key Developments
- Market Trend
- Future Prospective on growth and demand of Cardiac Prosthetics Devices
- Top Market Players by Revenue
4. Global Cardiac Prosthetic Devices Market, By Product Type, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Heart Valves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Mechanical Heart Valves
- Tissue Heart Valves
- Stented tissue valve
- Stentless tissue valve
- Transcatheter Heart Valves
- Pacemaker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Implantable pacemakers
- Single-Chamber Battery Pacemaker
- Dual-Chamber Battery Pacemaker
- Triple-Chamber Battery Pacemaker
- External Pacemaker
- Implantable pacemakers
5. Global Cardiac Prosthetic Devices Market, By End user, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others (Academic & Research Institutes and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
6. Global Cardiac Prosthetic Devices Market, By Region, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2021 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Artivion, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Edwards Lifesciences Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Siemens Healthcare Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LivaNova PLC (Sorin Group)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Asahi Kasei Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OSYPKA MEDICAL
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lepu Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MicroPort Scientific Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vitatron
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Koninklijke Philips N.V.,
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Progetti srl
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Shree Pacetronix Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
8. Section
- Research Methodology
- About Us
心臟人工器官市場：商業機會、成長要素、產業趨勢分析及2026-2035年預測
心臟假體設備市場報告：按產品類型、最終用戶和地區分類（2026-2034 年）
全球心臟假體市場規模、佔有率、趨勢和成長分析報告（2026-2034年）
心臟假體市場：2026年至2032年全球市場預測（依產品類型、手術、材料類型、適應症和最終用戶分類）
2026年全球人工心臟設備市場報告
心臟假體設備市場規模、佔有率和成長分析（按產品類型、材質類型、最終用途和地區分類）－2026-2033年產業預測
心臟假體設備市場（依產品、國家及地區）－2025 年至 2032 年全球產業分析、市場規模、市場佔有率及預測